Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antitumor activity of treosulfan in human lung carcinomas.
Köpf-Maier P, Sass G. Köpf-Maier P, et al. Among authors: sass g. Cancer Chemother Pharmacol. 1996;37(3):211-21. doi: 10.1007/BF00688319. Cancer Chemother Pharmacol. 1996. PMID: 8529280
Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives.
Moebus VJ, Stein R, Kieback DG, Runnebaum IB, Sass G, Kreienberg R. Moebus VJ, et al. Among authors: sass g. Anticancer Res. 1997 Mar-Apr;17(2A):815-21. Anticancer Res. 1997. PMID: 9137413
In vitro activity of titanocenedichloride versus cisplatin and doxorubicin in primary and recurrent epithelial ovarian cancer.
Kurbacher CM, Mallmann P, Kurbacher JA, Sass G, Andreotti PE, Rahmun A, Hübner H, Krebs D. Kurbacher CM, et al. Among authors: sass g. Anticancer Res. 1994 Sep-Oct;14(5A):1961-5. Anticancer Res. 1994. PMID: 7847834
In vitro activity of titanocenedichloride in human renal cell carcinoma compared to conventional antineoplastic agents.
Kurbacher CM, Nagel W, Mallmann P, Kurbacher JA, Sass G, Hübner H, Andreotti PE, Krebs D. Kurbacher CM, et al. Among authors: sass g. Anticancer Res. 1994 Jul-Aug;14(4A):1529-33. Anticancer Res. 1994. PMID: 7979181
Treosulfan in the treatment of advanced ovarian cancer: a randomised co-operative multicentre phase III-study.
Breitbach GP, Meden H, Schmid H, Kühn W, Sass G, Schach S, Schmidt-Rohde P, Bastert G; GTOC Study Group. Breitbach GP, et al. Among authors: sass g. Anticancer Res. 2002 Sep-Oct;22(5):2923-32. Anticancer Res. 2002. PMID: 12530019 Clinical Trial.
Antitumor activity of treosulfan against human breast carcinomas.
Köpf-Maier P, Sass G. Köpf-Maier P, et al. Among authors: sass g. Cancer Chemother Pharmacol. 1992;31(2):103-10. doi: 10.1007/BF00685095. Cancer Chemother Pharmacol. 1992. PMID: 1451231
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
Korfel A, Scheulen ME, Schmoll HJ, Gründel O, Harstrick A, Knoche M, Fels LM, Skorzec M, Bach F, Baumgart J, Sass G, Seeber S, Thiel E, Berdel WE. Korfel A, et al. Among authors: sass g. Clin Cancer Res. 1998 Nov;4(11):2701-8. Clin Cancer Res. 1998. PMID: 9829732 Clinical Trial.
In vitro activity of titanocenedichloride versus cisplatin in four ovarian carcinoma cell lines evaluated by a microtiter plate ATP bioluminescence assay.
Kurbacher CM, Bruckner HW, Andreotti PE, Kurbacher JA, Sass G, Krebs D. Kurbacher CM, et al. Among authors: sass g. Anticancer Drugs. 1995 Oct;6(5):697-704. doi: 10.1097/00001813-199510000-00010. Anticancer Drugs. 1995. PMID: 8845481
Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell lines.
Harstrick A, Schmoll HJ, Sass G, Poliwoda H, Rustum Y. Harstrick A, et al. Among authors: sass g. Eur J Cancer. 1993;29A(7):1000-2. doi: 10.1016/s0959-8049(05)80210-2. Eur J Cancer. 1993. PMID: 8499130
Phase-I tolerability study of 5-methyltetrahydrofolate in combination with a 4-hour infusion of 5-Fluorouracil in cancer-patients.
Korfel A, Kreuser E, Hoeffken G, Baumgart J, Sass G, Thiel E, Berdel W. Korfel A, et al. Among authors: sass g. Int J Oncol. 1995 Jul;7(1):65-8. doi: 10.3892/ijo.7.1.65. Int J Oncol. 1995. PMID: 21552807
100 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback